Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.

International journal of antimicrobial agents - 1 Jul 2023

Cai Jiehao, Chen Mingliang, Liu Qiyi, Luo Jiayuan, Yuan Lingyue, Chen Yanxin, Chen Min, Zeng Mei

Abstract excerpt

The number of cases of pertussis has been increasing since 2014 in China, with high prevalence of macrolide resistance in ptxP1 isolates and low prevalence in ptxP3 isolates. This study aimed to investigate the dynamic changes in the B. pertussis population from paediatric patients and household contacts in Shanghai between 2018 and 2022. Clinical data of laboratory-confirmed cases of pertussis were analysed,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Bordetella pertussis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Erythromycin

Share to Macrolides

Share to Pertussis Vaccine

Share to Whooping Cough

Source

Identifiers

PMID: 37127126
DOI: 10.1016/j.ijantimicag.2023.106835

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Domination of an emerging erythromycin-resistant ptxP3 Bordetella pertussis clone in Shanghai, China.PMID 37127126Read ↗

Genomic surveillance reveals global spread of macrolide-resistant Bordetella pertussis linked to vaccine changes.Semantic proximity Read ↗

Emergence and spread of MT28 ptxP3 allele macrolide-resistant Bordetella pertussis from 2021 to 2022 in China.Semantic proximity Read ↗

Sharp rise in high-virulence Bordetella pertussis with macrolides resistance in Northern ChinaSemantic proximity Read ↗

Genomic Surveillance Reveals Global Spread of Macrolide-Resistant <i>Bordetella pertussis</i> Linked to Vaccine ChangesSemantic proximity Read ↗

Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by<i>ptxP3</i>macrolide-resistant<i>Bordetella pertussis</i>MT28 clone in China: a genomic epidemiology studySemantic proximity Read ↗

Genomic epidemiology and evolutionary dynamics of Bordetella pertussis: A comparative study between China and Global Strains (2018-2024).Semantic proximity Read ↗

Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016–2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides ResistanceSemantic proximity Read ↗

Emergence of Erythromycin-Resistant and Pertactin- and Filamentous Hemagglutinin-Deficient Bordetella pertussis Strains — Beijing, China, 2022–2023Semantic proximity Read ↗

Emergence of macrolide-resistant<i>Bordetella pertussis</i>in France, 2024: out of ChinaSemantic proximity Read ↗

Molecular epidemiology and genomic features of Bordetella pertussis in Tianjin, China, 2023.Semantic proximity Read ↗

Macrolide-Resistant Bordetella pertussis in Hong Kong: Evidence for Post-COVID-19 Emergence of ptxP3-Lineage MT28 Clone from a Hospital-Based Surveillance StudySemantic proximity Read ↗

The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young Children with the Co-purified aPV vaccination: a 5 years retrospective studySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.